Results 181 to 190 of about 55,779 (204)
Some of the next articles are maybe not open access.
Dengue vaccines: preparing to roll back dengue.
Current opinion in investigational drugs (London, England : 2000), 2003Dengue is an emerging viral pathogen of growing global importance, infecting up to 100 million people annually. Although there have been many efforts over the last six decades to produce a vaccine to combat this infection, few have been able to meet the challenges posed by the unusual interplay between this virus and its human host.
Jacobs, M., Young, P. R.
openaire +3 more sources
Nihon rinsho. Japanese journal of clinical medicine, 2011
Dengue fever is the most important mosquito-borne viral disease in the world, for which preventive vaccines are urgently required. Several strategies have been used for dengue tetravalent vaccine development. Strategies with traditional attenuation, chimerization, engineered attenuation are in the more advanced stages. In addition, inactivated, subunit,
openaire +1 more source
Dengue fever is the most important mosquito-borne viral disease in the world, for which preventive vaccines are urgently required. Several strategies have been used for dengue tetravalent vaccine development. Strategies with traditional attenuation, chimerization, engineered attenuation are in the more advanced stages. In addition, inactivated, subunit,
openaire +1 more source
Targets and strategies for vaccine development against dengue viruses
Biomedicine and Pharmacotherapy, 2021Wen-Hung Wang +2 more
exaly
Prospects for a dengue virus vaccine
Nature Reviews Microbiology, 2007Stephen S Whitehead, Anna P Durbin
exaly
Review of dengue virus and the development of a vaccine
Biotechnology Advances, 2011Suh-Chin Wu, Michael Butler
exaly